21-hydroxylase deficiency

Annals of the New York Academy of Sciences

Volumn 816, Issue , 1997, Pages 219-229

  Newfield, Ron S ^a   New, Maria I ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; MINERALOCORTICOID; STEROID 21 MONOOXYGENASE;

ADRENAL HYPERPLASIA; CONFERENCE PAPER; PRENATAL DIAGNOSIS; STEROID 21 MONOOXYGENASE DEFICIENCY;

EID: 0030841794     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52145.x     Document Type: Conference Paper

References (25)

1. NEW, M. I., B. DUPONT, K. GRUMBACH & L. S. LEVINE. 1982. Congenital adrenal hyperplasia and related conditions. In The Metabolic Basis of Inherited Disease. 5th edit. J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, & M. D. Brown, Eds.: 973-1000. McGraw-Hill. New York.
2. NEW, M. I., L. GHIZZONI & P. W. SPEISER. 1995. Update on congenital adrenal hyperplasia. In Pediatric Endocrinology. 3rd edit. F. Lifshitz, Ed. Chapter 16: 305-320. Marcel Dekker. New York.
3. SPEISER, P. W., B. DUPONT, P. RUBINSTEIN, A. PIAZZA, A. KASTELAN & M. I. NEW. 1985. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am. J. Hum. Genet. 37: 650-667.
4. BRANCHAUD, C. L. & B. E. P. MURPHY. 1992. Physiopathology of the fetal adrenal. In Hormones and Fetal Pathophysiology. J. R. Pasqualini & R. Scholler, Eds.: 53. Marcel Dekker. New York.
5. KLINGENSMITH, G. J., S. C.GARCIA, H. W. JONES, C. J. MIGEON & R. M. BLIZZARD. 1977. Glucocorticoid treatment of gills with congenital adrenal hyperplasia: Effects on height, sexual maturation, and fertility. J. Pediatr. 90: 966.
6. PANG, S., F. M. KENNY, T. P. FOLEY & A. L. DRASH. 1977. Growth and sexual maturation in treated congenital adrenal hyperplasia. In Congenital Adrenal Hyperplasia. P. A. Lee, L. P. Plotnick, A. A. Kowarski, C. J. Migeon, Eds.: 233. University Park Press. Baltimore, MD.
7. NEW, M. I., J. M. GERTNER, P. W. SPEISER & P. DEL BALZO. 1989. Growth and final height in classical and nonclassical 21-hydroxylase deficiency. J. Endocrinol. Invest. 12: 91-95.
8. JONES, H. W. & B. S. VERKAUF. 1971. Congenital adrenal hyperplasia: Age at menarche and related events at puberty. Am. J. Obstet. Gynecol. 109: 292.
9. KLINGENSMITH, G. J., A. C. WENTZ, W. J. MEYER & C. J. MIGEON. 1976. Gonadotropin output in congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 43: 933.
10. GRANOFF, A. B. 1981. Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia. J. Adolesc. Health Care. 2: 23.
11. HAGUE, W. M., J. ADAMS, C. RODDA, et al. 1990. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin. Endocrinol. 33: 501-510.
12. GHIZZONI, L., R. VIRDIS, A. VOTTERO, M. CAPRA, M. E. STREET, M. ZAMPOLLI, L. IBANEZ & S. BERNASCONI. 1996. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 81: 601-606.
13. BAKER, S. W. 1981. Psychological management of intersex children. In The Intersex Child. Z. Laron, Ed. Pediatric Adolescent Endocrinology. Vol. 8: 261. S. Karger. Basel.
14. JARESCH, S., E. KORNELY, H. KLEY & R. SCHLAGHECKE. 1992. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 74:685-689.
15. WISCHUSEN, J., H. W. G. BAKER & B. HUDSON. 1981. Reversible male infertility in late onset congenital adrenal hyperplasia. Clin. Endocrinol. 14: 571.
16. AUGARTAN, A., R. WEISSENBERG, C. PARIENTE & J. SACK. 1991. Reversible male infertility in late onset congenital adrenal hyperplasia. J. Endocrinol. Invest. 14: 237-240.
17. WHITE, P. C., M. I. NEW & B. DUPONT. 1987. Congenital adrenal hyperplasia (Part I). N. Engl. J. Med. 316: 1519-1524.
18. MERCADO, A. B., R. C. WILSON, K. C. CHENG, J-Q. WEI & M. I. NEW. 1995. Extensive personal experience with prenatal diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 80: 2014-2020.
19. WILSON, R. C., A. B. MERCADO, K. C. CHENG & M. I. NEW. 1995. Steroid 21-hydroxylase deficiency: Genotype may not predict phenotype. J. Clin. Endocrinol. Metab. 80: 2322-2339.
20. NEW, M. I. & R. S. NEWFIELD. 1997. Congenital adrenal hyperplasia. In Current Therapy in Endocrinology and Metabolism. 6th edit. C. W. Bardin, Ed.: 179-187. Mosby-Year Book. Philadelphia, PA.
21. HENDREN, W. H. & P. K. DONAHOE. 1980. Correction of congenital abnormalities of the vagina and perineum. J. Pediatr. Surg. 15: 751.
22. HENDREN, W. H. & J. D. CRAWFORD. 1969. Adrenogenital syndrome: The anatomy of the anomaly and its repair. J. Pediatr. Surg. 4: 49.
23. ROSLER, A., L. S. LEVINE, B. SCHNEIDER, M. NOVOGRODER & M. I. NEW. 1977. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 45: 500-512.
24. LEVINE, L. S. & S. PANG. 1994. Prenatal diagnosis and treatment of congenital adrenal hyperplasia. J. Pediatr. Endocrinol. 7: 193-200.
25. NEW, M. I. & L. S. LEVINE. 1973. Congenital adrenal hyperplasia. In Advances in Human Genetics. Vol. 4. H. Harris & K. Hirschhorn, Eds.: 251-326. Plenum Press. New York.